Results 321 to 330 of about 821,293 (407)

Characterizing Apixaban Pharmacokinetics Through Physiologically‐Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Apixaban, a factor Xa inhibitor, is a direct oral anticoagulant with a well‐balanced elimination; it is eliminated evenly via feces, urine (with no active secretion), and as metabolites after oral administration. The common understanding is that biliary secretion and enterohepatic circulation (EHC) of apixaban are limited in humans, and that ...
Toshiaki Tsuchitani   +3 more
wiley   +1 more source

Distal Cholangiocarcinoma with Synchronous Intramural Bile Duct Metastasis: A Case Report. [PDF]

open access: yesSurg Case Rep
Kiuchi R   +9 more
europepmc   +1 more source

Late mortality and morbidity after liver transplantation. [PDF]

open access: yes, 1987
Esquivel, CO   +8 more
core  

Machine Learning‐Based Risk‐Adjusted CUSUM Control Chart for Monitoring Readmission Rate Following PTBD Catheter Placement

open access: yesQuality and Reliability Engineering International, EarlyView.
ABSTRACT Percutaneous transhepatic biliary drainage (PTBD) catheter placement is known to have a high readmission rate. This work focuses on monitoring the change in readmission rate after a new clinical paradigm for post‐procedural care is implemented for the PTBD procedures.
Muhammed Aljifri   +2 more
wiley   +1 more source

Patient outcomes and healthcare costs following iatrogenic bile duct injuries: A national multicentre retrospective cohort study. [PDF]

open access: yesAnn Hepatobiliary Pancreat Surg
Mullen C   +13 more
europepmc   +1 more source

Re-do laparoscopic common bile duct exploration for recurrent common bile duct stones: a single-center retrospective cohort study. [PDF]

open access: yesAnn Surg Treat Res
Lee IH   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy